Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Immuno-Oncology/Oncology
Using Humanized In Vivo Models for Preclinical Antibody Development: A Case Study

Using Humanized In Vivo Models for Preclinical Antibody Development: A Case Study

Published Date February 3, 2021

Loading, please wait

Error - something went wrong!

Don't miss new content. Subscribe to our monthly newsletter, JAX Pulse!

Thank you!

Previous Article

Shaping the Future of the Immunotherapeutic Development Pipeline

For the first time ever, drug developers have the option to accurately assess immunotoxicity and drug efficacy in the same study utilizing a novel humanized platform.
Next Flipbook

Case Study: Evaluation of the Anti-Tumor Efficacy of a Bispecific in Two Novel In Vivo Systems

The NSG Humanized Mouse platform is an efficient way to test bispecific antibodies, including CD3 binding bispecific. This case study highlights our recent data.

Other content in this Stream

about 1 month ago
Cancer immunotherapy: getting a little help from ourselves

We review strategies and mouse models used to develop highly promising therapeutic treatments using the body’s own immune system in the fight against cancer.

Learn More
about 2 months ago
Comparing Immune-Humanized Mouse Platforms for Preclinical Applications

February 20, 2024 - During this presentation, we compare strategies for immune humanization of NSG variants to support translatable preclinical immunology and oncology research.

Watch Video
3 months ago
Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research

January 16, 2024 - In this webinar, we discuss the most widely used immunodeficient mouse models and essential considerations for selecting the most appropriate model.

Watch Video
6 months ago
New Immune-humanized Models Support More Diverse Human Immune Cell Lineages

In this webinar, we will introduce two new enhanced NSG models developed at The Jackson Laboratory: NSG-SGM3-IL15 and NSG-FLT3.

Watch Video
The Promise of Cancer Genomics

Learn about the advantages of using genomic-based strategies in the fight against cancer

Learn More
Exploring Cancer Research: Tools and Technologies

Find out which tools and technologies are used by scientists to advance the field of cancer research, including sequencing, cell-based models of cancer, and mouse models of cancer.

Learn More
over 1 year ago
Leveraging Gene Therapy to Achieve Long-Term Continuous or Controllable Expression of Biotherapeutics

Leading this presentation is guest speaker Dr. Timothy Cripe from Nationwide Children’s Hospital and The Ohio State University.

Watch Video
over 1 year ago
JAX Clinical Knowledgebase - Identify Resistance Variants in Preclinical Drug Testing

One of the major challenges oncologists are often faced with when managing precision cancer treatment is acquired drug resistance.

Learn More
over 1 year ago
Making a Case for Preclinical Data - The JAX Clinical Knowledgebase

The JAX Clinical Knowledgebase (CKB) is a relational database that contains data associated with cancer variants, tumor types, and therapies.

Learn More
over 1 year ago
A Novel In Vivo Model to Simultaneously Assess Efficacy and Toxicity of Chimeric Antigen Receptor T-Cell Immunotherapy

Read Flipbook
Exploring Cancer: Biology and Inheritance

Discover the fundamental properties of cancer cells and explore the genetic basis, inheritance, risk factors and prevention of this disease.

Learn More
almost 2 years ago
Immune-Humanized PDX Model-Estrogen-Independent, Hormone Receptor-Positive Metastatic Breast Cancer

The most common type of breast cancer is estrogen receptor-positive (ER+). ER+ tumors can be successfully treated with hormone therapy, but many tumors acquire endocrine resistance which limits treatm

Watch Video
almost 2 years ago
Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft Platforms

This on-demand webinar provides strategies for using PDX models in predictive preclinical research and an introduction to PDX models for immuno-oncology research.

Watch Video
about 2 years ago
How To Make Your New NSG Variant in a Fraction of the Time

CRISPR/Cas9 can quickly generate new translational mouse models directly on the genetic background needed for your preclinical research. This saves valuable research time by reducing the need for...

Learn More
about 2 years ago
Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.

Read Flipbook
about 2 years ago
Designing Your In Vivo Studies

September 9, 2021 - Learn about unique experimental design considerations and critically important topics that affect the reproducibility of your In Vivo research studies.

Watch Video
about 2 years ago
JAX Tech Talk Episode 48: Developing Immunotherapies with Hu-NSG-MHC I/II DKO Mice (Jan. 11, 2022)

January 11, 2022 - In this episode, we will discuss using PBMC humanized NSG-MHC I/II DKO mice in preclinical research to develop and assess efficacy of human immuno-therapeutics.

Watch Video
over 2 years ago
JAX Tech Talk Episode 47: Let’s Talk Navigating the JAX Clinical Knowledgebase (Dec. 14, 2021)

oin us as we talk with a JAX-CKB curator about what goes into the knowledgebase.

Watch Video
over 2 years ago
Introduction to In Vivo Platforms for Cancer Immunotherapy

Grace Berryhill, Ph.D. provides an overview of in vivo platforms being used to improve the translational relevance of cancer immunotherapies.

Watch Video
over 2 years ago
Human KIT+ Myeloid Cells Facilitate Visceral Metastasis By Melanoma

Chun Yu, Ph.D., Associate Research Scientist at The Jackson Laboratory speaks about Human KIT+ myeloid cells and how they facilitate visceral metastasis by melanoma.

Watch Video

Recommended for you

Return to Home

© The Jackson Laboratory